{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:34:27Z","timestamp":1790534067468,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T00:00:00Z","timestamp":1527206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T00:00:00Z","timestamp":1527206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Post-translational modifications (PTMs) are key modulators of protein function. Huntington disease (HD) is a dominantly inherited neurodegenerative disorder caused by an expanded CAG trinucleotide repeat in the huntingtin (\n                    <jats:italic>HTT<\/jats:italic>\n                    ) gene. A spectrum of PTMs have been shown to modify the normal functions of HTT, including proteolysis, phosphorylation and lipidation, but the full contribution of these PTMs to the molecular pathogenesis of HD remains unclear. In this study, we examine all commonly occurring missense mutations in\n                    <jats:italic>HTT<\/jats:italic>\n                    to identify potential human modifiers of HTT PTMs relevant to HD biology. We reveal a SNP that modifies post-translational myristoylation of HTT, resulting in downstream alterations to toxic HTT proteolysis in human cells. This is the first SNP shown to functionally modify a PTM in HD and the first validated genetic modifier of post-translational myristoylation. This SNP is a high-priority candidate modifier of HD phenotypes and may illuminate HD biology in human studies.\n                  <\/jats:p>","DOI":"10.1038\/s41598-018-25903-w","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T13:41:15Z","timestamp":1526650875000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["A human huntingtin SNP alters post-translational modification and pathogenic proteolysis of the protein causing Huntington disease"],"prefix":"10.1038","volume":"8","author":[{"given":"D. D. O.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"Slama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,25]]},"reference":[{"key":"25903_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72, 971\u2013983 (1993).","journal-title":"Cell"},{"key":"25903_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/81593","volume":"26","author":"I Dragatsis","year":"2000","unstructured":"Dragatsis, I., Levine, M. S. & Zeitlin, S. Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat. Genet. 26, 300\u2013306 (2000).","journal-title":"Nat. Genet."},{"key":"25903_CR3","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.neuron.2010.06.027","volume":"67","author":"JD Godin","year":"2010","unstructured":"Godin, J. D. et al. Huntingtin Is Required for Mitotic Spindle Orientation and Mammalian Neurogenesis. Neuron 67, 392\u2013406 (2010).","journal-title":"Neuron"},{"key":"25903_CR4","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1523\/JNEUROSCI.1870-13.2014","volume":"34","author":"YC Wong","year":"2014","unstructured":"Wong, Y. C. & Holzbaur, E. L. F. The Regulation of Autophagosome Dynamics by Huntingtin and HAP1 Is Disrupted by Expression of Mutant Huntingtin, Leading to Defective Cargo Degradation. J. Neurosci. 34, 1293\u20131305 (2014).","journal-title":"J. Neurosci."},{"key":"25903_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tins.2014.09.003","volume":"38","author":"DDO Martin","year":"2015","unstructured":"Martin, D. D. O., Ladha, S., Ehrnhoefer, D. E. & Hayden, M. R. Autophagy in Huntington disease and huntingtin in autophagy. Trends Neurosci. 38, 26\u201335 (2015).","journal-title":"Trends Neurosci."},{"key":"25903_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","volume":"65","author":"DR Langbehn","year":"2004","unstructured":"Langbehn, D. R., Brinkman, R. R., Falush, D., Paulsen, J. S. & Hayden, M. R. A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length. Clin. Genet. 65, 267\u2013277 (2004).","journal-title":"Clin. Genet."},{"key":"25903_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nn.4014","volume":"18","author":"K Be\u010danovi\u0107","year":"2015","unstructured":"Be\u010danovi\u0107, K. et al. A SNP in the HTT promoter alters NF-\u03baB binding and is a bidirectional genetic modifier of Huntington disease. Nat. Neurosci. 18, 807\u2013816 (2015).","journal-title":"Nat. Neurosci."},{"key":"25903_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","volume":"162","author":"J-M Lee","year":"2015","unstructured":"Lee, J.-M. et al. Identification of genetic factors that modify clinical onset of Huntington\u2019s disease. Cell 162, 516\u2013526 (2015).","journal-title":"Cell"},{"key":"25903_CR9","first-page":"475","volume":"17","author":"DE Ehrnhoefer","year":"2011","unstructured":"Ehrnhoefer, D. E., Sutton, L. & Hayden, M. R. SmallChanges, Big Impact: Posttranslational Modifications and Function of Huntingtin in Huntington Disease. Neurosci. 17, 475\u2013492 (2011).","journal-title":"Neurosci."},{"key":"25903_CR10","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/hmg\/ddi165","volume":"14","author":"SC Warby","year":"2005","unstructured":"Warby, S. C. et al. Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo. Hum. Mol. Genet. 14, 1569\u20131577 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"25903_CR11","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.15252\/embj.201490808","volume":"34","author":"M-T El-Daher","year":"2015","unstructured":"El-Daher, M.-T. et al. Huntingtin proteolysis releases non-polyQ fragments that cause toxicity through dynamin 1 dysregulation. EMBO J. 34, 2255\u201371 (2015).","journal-title":"EMBO J."},{"key":"25903_CR12","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","volume":"125","author":"RK Graham","year":"2006","unstructured":"Graham, R. K. et al. Cleavage at the Caspase-6 Site Is Required for Neuronal Dysfunction and Degeneration Due to Mutant Huntingtin. Cell 125, 1179\u20131191 (2006).","journal-title":"Cell"},{"key":"25903_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1096\/fj.11-182360","volume":"26","author":"DDO Martin","year":"2012","unstructured":"Martin, D. D. O. et al. Tandem reporter assay for myristoylated proteins post-translationally (TRAMPP) identifies novel substrates for post-translational myristoylation: PKC\u03b5, a case study. FASEB J. 26, 13\u201328 (2012).","journal-title":"FASEB J."},{"key":"25903_CR14","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1093\/hmg\/ddu027","volume":"23","author":"DDO Martin","year":"2014","unstructured":"Martin, D. D. O. et al. Identification of a post-translationally myristoylated autophagy-inducing domain released by caspase cleavage of huntingtin. Hum. Mol. Genet. 23, 3166\u20133179 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"25903_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1042\/BST20140281","volume":"43","author":"DDO Martin","year":"2015","unstructured":"Martin, D. D. O. & Hayden, M. R. Post-translational myristoylation at the cross roads of cell death, autophagy and neurodegeneration. Biochem. Soc. Trans. 43, 229\u2013234 (2015).","journal-title":"Biochem. Soc. Trans."},{"key":"25903_CR16","doi-asserted-by":"publisher","unstructured":"Kay, C. et al. Huntingtin Haplotypes Provide Prioritized Target Panels for Allele-specific Silencing in Huntington Disease Patients of European Ancestry. Molecular Therapy, https:\/\/doi.org\/10.1038\/mt.2015.128 (2015).","DOI":"10.1038\/mt.2015.128"},{"key":"25903_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.bbrc.2012.03.033","volume":"420","author":"A Zuleta","year":"2012","unstructured":"Zuleta, A., Vidal, R. L., Armentano, D., Parsons, G. & Hetz, C. AAV-mediated delivery of the transcription factor XBP1s into the striatum reduces mutant Huntingtin aggregation in a mouse model of Huntington\u2019s disease. Biochem. Biophys. Res. Commun. 420, 558\u2013563 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"25903_CR18","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1194\/jlr.D002790","volume":"51","author":"MC Yap","year":"2010","unstructured":"Yap, M. C. et al. Rapid and selective detection of fatty acylated proteins using omega-alkynyl-fatty acids and click chemistry. J. Lipid Res. 51, 1566\u201380 (2010).","journal-title":"J. Lipid Res."},{"key":"25903_CR19","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). 8627 (2016)."},{"key":"25903_CR20","doi-asserted-by":"crossref","unstructured":"Skotte, N. H. et al. Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: Providing a therapeutic option for all Huntington disease patients. PLoS One 9 (2014).","DOI":"10.1371\/journal.pone.0107434"},{"key":"25903_CR21","doi-asserted-by":"publisher","first-page":"22490","DOI":"10.1074\/jbc.273.35.22490","volume":"273","author":"KK Wang","year":"1998","unstructured":"Wang, K. K. et al. Simultaneous degradation of alphaII- and betaII-spectrin by caspase 3 (CPP32) in apoptotic cells. J. Biol. Chem. 273, 22490\u201322497 (1998).","journal-title":"J. Biol. Chem."},{"key":"25903_CR22","doi-asserted-by":"publisher","first-page":"e1153778","DOI":"10.1080\/21675511.2016.1153778","volume":"4","author":"JJ Weber","year":"2016","unstructured":"Weber, J. J., Ortiz Rios, M. M., Riess, O., Clemens, L. E. & Nguyen, H. P. The calpain-suppressing effects of olesoxime in Huntington\u2019s disease. Rare Dis. 4, e1153778 (2016).","journal-title":"Rare Dis."},{"key":"25903_CR23","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","volume":"9","author":"F Trettel","year":"2000","unstructured":"Trettel, F. Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells. Hum. Mol. Genet. 9, 2799\u20132809 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"25903_CR24","doi-asserted-by":"publisher","first-page":"16889","DOI":"10.1073\/pnas.1420103111","volume":"111","author":"J Ochaba","year":"2014","unstructured":"Ochaba, J. et al. Potential function for the Huntingtin protein as a scaffold for selective autophagy. Proc. Natl. Acad. Sci. 111, 16889\u201316894 (2014).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"25903_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.nbd.2014.12.030","volume":"76","author":"BKY Wong","year":"2015","unstructured":"Wong, B. K. Y. et al. Partial rescue of some features of Huntington Disease in the genetic absence of caspase-6 in YAC128 mice. Neurobiol. Dis. 76, 24\u201336 (2015).","journal-title":"Neurobiol. Dis."},{"key":"25903_CR26","doi-asserted-by":"publisher","first-page":"e27680","DOI":"10.1371\/journal.pone.0027680","volume":"6","author":"DE Ehrnhoefer","year":"2011","unstructured":"Ehrnhoefer, D. E. et al. A quantitative method for the specific assessment of caspase-6 activity in cell culture. PLoS One 6, e27680 (2011).","journal-title":"PLoS One"},{"key":"25903_CR27","doi-asserted-by":"crossref","unstructured":"Choi, Y., Sims, G. E., Murphy, S., Miller, J. R. & Chan, A. P. Predicting the Functional Effect of Amino Acid Substitutions and Indels. PLoS One 7 (2012).","DOI":"10.1371\/journal.pone.0046688"},{"key":"25903_CR28","doi-asserted-by":"publisher","first-page":"W452","DOI":"10.1093\/nar\/gks539","volume":"40","author":"N-L Sim","year":"2012","unstructured":"Sim, N.-L. et al. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 40, W452\u20137 (2012).","journal-title":"Nucleic Acids Res."},{"key":"25903_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-16-S8-S1","volume":"16","author":"M Hecht","year":"2015","unstructured":"Hecht, M., Bromberg, Y. & Rost, B. Better prediction of functional effects for sequence variants. BMC Genomics 16, S1 (2015).","journal-title":"BMC Genomics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25903-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25903-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25903-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:37:42Z","timestamp":1671583062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25903-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,25]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["25903"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-25903-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/129536","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,25]]},"assertion":[{"value":"23 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8096"}}